FDA 483 - Sparhawk Laboratories Inc - March 23, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sparhawk Laboratories Inc, an animal drug manufacturer in Lenexa, KS, received a Form 483 with three observations during an FDA inspection. The firm was cited for inadequate computer controls and data integrity issues, including a repeat observation regarding HPLC data and unprotected spreadsheet formulas. Additionally, the inspection revealed deficiencies in aseptic process validation and a lack of established procedures for preventing microbiological contamination, specifically concerning employee qualification for aseptic operations.
ID · fbae89d7-7f56-411d-8ad5-30db5056a74a